These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients. Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670 [TBL] [Abstract][Full Text] [Related]
4. Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients. Benzi L; Trischitta V; Ciccarone A; Cecchetti P; Brunetti A; Squatrito S; Marchetti P; Vigneri R; Navalesi R Diabetes; 1990 Jul; 39(7):844-9. PubMed ID: 2191888 [TBL] [Abstract][Full Text] [Related]
5. Insulin internalization into monocytes is decreased in patients with type II diabetes mellitus. Trischitta V; Gullo D; Squatrito S; Pezzino V; Goldfine ID; Vigneri R J Clin Endocrinol Metab; 1986 Mar; 62(3):522-8. PubMed ID: 3944236 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. DeFronzo RA; Barzilai N; Simonson DC J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo. Fantus IG; Brosseau R J Clin Endocrinol Metab; 1986 Oct; 63(4):898-905. PubMed ID: 3745404 [TBL] [Abstract][Full Text] [Related]
8. Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. Nosadini R; Avogaro A; Trevisan R; Valerio A; Tessari P; Duner E; Tiengo A; Velussi M; Del Prato S; De Kreutzenberg S Diabetes Care; 1987; 10(1):62-7. PubMed ID: 3552515 [TBL] [Abstract][Full Text] [Related]
9. Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes. Lord JM; White SI; Bailey CJ; Atkins TW; Fletcher RF; Taylor KG Br Med J (Clin Res Ed); 1983 Mar; 286(6368):830-1. PubMed ID: 6403102 [TBL] [Abstract][Full Text] [Related]
10. Insulin receptors on monocytes and erythrocytes from obese patients. De Pirro R; Fusco A; Lauro R; Testa I; Ferretti G; De Martinis C J Clin Endocrinol Metab; 1980 Dec; 51(6):1437-9. PubMed ID: 7002953 [TBL] [Abstract][Full Text] [Related]
11. Gastric inhibitory polypeptide in obesity and diabetes mellitus. Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812 [TBL] [Abstract][Full Text] [Related]
12. Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects. Vague P; Juhan-Vague I; Alessi MC; Badier C; Valadier J Thromb Haemost; 1987 Jun; 57(3):326-8. PubMed ID: 3310318 [TBL] [Abstract][Full Text] [Related]
13. Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. Trischitta V; Brunetti A; Chiavetta A; Benzi L; Papa V; Vigneri R Diabetes; 1989 Dec; 38(12):1579-84. PubMed ID: 2684714 [TBL] [Abstract][Full Text] [Related]
14. The effects of metformin and diet on plasma testosterone and leptin levels in obese men. Ozata M; Oktenli C; Bingol N; Ozdemir IC Obes Res; 2001 Nov; 9(11):662-7. PubMed ID: 11707532 [TBL] [Abstract][Full Text] [Related]
15. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. Dandona P; Aljada A; Ghanim H; Mohanty P; Tripathy C; Hofmeyer D; Chaudhuri A J Clin Endocrinol Metab; 2004 Oct; 89(10):5043-7. PubMed ID: 15472203 [TBL] [Abstract][Full Text] [Related]
16. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. DeFronzo R; Deibert D; Hendler R; Felig P; Soman V J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552 [TBL] [Abstract][Full Text] [Related]
17. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp. Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652 [TBL] [Abstract][Full Text] [Related]
18. Effect of metformin on insulin-stimulated tyrosine kinase activity of erythrocytes from obese women with normal glucose tolerance. Santos RF; Nomizo R; Bopsco A; Wajchenberg BL; Reaven GM; Azhar S Diabetes Metab; 1997 Apr; 23(2):143-8. PubMed ID: 9137903 [TBL] [Abstract][Full Text] [Related]
19. Insulin binding to monocytes in obese patients treated with carbohydrate restriction and changes in physical activity. Misbin RI; Moffa AM; Kappy MS J Clin Endocrinol Metab; 1983 Feb; 56(2):273-8. PubMed ID: 6337175 [TBL] [Abstract][Full Text] [Related]
20. Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting. Bar RS; Gorden P; Roth J; Kahn CR; De Meyts P J Clin Invest; 1976 Nov; 58(5):1123-35. PubMed ID: 993336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]